NEUROPEPTIDE-Y, PEPTIDE-YY AND C-TERMINAL FRAGMENTS RELEASE HISTAMINE FROM RAT PERITONEAL MAST-CELLS

被引:47
作者
GRUNDEMAR, L
HAKANSON, R
机构
[1] Department of Pharmacology, University of Lund, Lund
关键词
NEUROPEPTIDE-Y; PEPTIDE-YY; C-TERMINAL FRAGMENTS; HISTAMINE RELEASE; MAST CELLS OF RAT;
D O I
10.1111/j.1476-5381.1991.tb12505.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 Neuropeptide Y (NPY) and peptide YY (PYY) seem to act on at least two receptor sybtypes, Y1 and Y2. The Y-receptor requires the whole C-terminally amidated NPY/PYY molecule whereas the Y2-receptor in addition recognizes C-terminal fragments of the two peptides. The present study was designed to elucidate whether NPY and related peptides were able to release histamine from isolated peritoneal mast cells of the rat. 2 NPY, NPY 15-36, NPY 22-36, NPY 26-36 and desamido-NPY evoked a concentration-dependent release of mast-cell histamine. The pEC15 values for NPY 15-36 and NPY 22-36 were higher, while the pEC15 value for NPY 26-36 was lower than that for NPY. At the highest concentration tested (0.1 mM), NPY and its C-terminal fragments released between 30 and 40% of the total histamine content. At the same concentration desamido-NPY released about 20%. 3 PYY and PYY 15-36 also evoked a concentration-dependent release of mast-cell histamine. PYY was more effective than PYY 15-36 since, at 0.1 mM, PYY released about 33%, while PYY 15-36 released about 15% of the total histamine content. Pancreatic polypeptide (PP) and the Y1-receptor-selective agonist [Pro34]NPY were virtually inactive. 4 The effect profile of the NPY/PYY-related peptides suggests that they act on the mast cells by a mechanism that does not involve either of the receptor subtypes hitherto described. The kinetics of the NPY-evoked histamine release may suggest that positively charged amino acid residues of NPY/PYY release mast-cell histamine by a non-receptor mechanism, as has been suggested for substance P and other basic peptides.
引用
收藏
页码:776 / 778
页数:3
相关论文
共 24 条
[1]  
BOTTCHER G, 1984, REGUL PEPTIDES, V8, P261, DOI 10.1016/0167-0115(84)90034-X
[2]  
BOUBLIK J, 1989, INT J PEPT PROT RES, V33, P11
[3]   SYNTHESIS AND HYPERTENSIVE ACTIVITY OF NEUROPEPTIDE-Y FRAGMENTS AND ANALOGS WITH MODIFIED N-TERMINI OR C-TERMINI OR D-SUBSTITUTIONS [J].
BOUBLIK, JH ;
SCOTT, NA ;
BROWN, MR ;
RIVIER, JE .
JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (03) :597-601
[4]   NEUROPEPTIDE-Y CO-EXISTS AND CO-OPERATES WITH NORADRENALINE IN PERIVASCULAR NERVE-FIBERS [J].
EKBLAD, E ;
EDVINSSON, L ;
WAHLESTEDT, C ;
UDDMAN, R ;
HAKANSON, R ;
SUNDLER, F .
REGULATORY PEPTIDES, 1984, 8 (03) :225-235
[5]   EFFECTS OF VARIOUS NEUROPEPTIDE-Y PEPTIDE-YY FRAGMENTS ON ELECTRICALLY-EVOKED CONTRACTIONS OF THE RAT VAS-DEFERENS [J].
GRUNDEMAR, L ;
HAKANSON, R .
BRITISH JOURNAL OF PHARMACOLOGY, 1990, 100 (01) :190-192
[6]   BIPHASIC BLOOD-PRESSURE RESPONSE TO NEUROPEPTIDE-Y IN ANESTHETIZED RATS [J].
GRUNDEMAR, L ;
WAHLESTEDT, C ;
SHEN, GH ;
ZUKOWSKAGROJEC, Z ;
HAKANSON, R .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 179 (1-2) :83-87
[7]  
GRUNDEMAR L, 1991, IN PRESS BR J PHARM
[8]   IMPROVED FLUOROMETRIC ASSAY OF HISTAMINE - CONDENSATION WITH O-PHTHALALDEHYDE AT -20 DEGREES-C [J].
HAKANSON, R ;
RONNBERG, AL .
ANALYTICAL BIOCHEMISTRY, 1974, 60 (02) :560-567
[9]   C-TERMINAL MODIFICATIONS OF NEUROPEPTIDE-Y AND ITS ANALOGS LEADING TO SELECTIVITY FOR THE MOUSE-BRAIN RECEPTOR OVER THE PORCINE SPLEEN RECEPTOR [J].
KRSTENANSKY, JL ;
OWEN, TJ ;
PAYNE, MH ;
SHATZER, SA ;
BUCK, SH .
NEUROPEPTIDES, 1990, 17 (03) :117-120
[10]   HISTAMINE-RELEASE INDUCED BY NEUROTENSIN FROM RAT PERITONEAL MAST-CELLS [J].
KUROSE, M ;
SAEKI, K .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1981, 76 (2-3) :129-136